We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVB icon
2826
Nuvation Bio
NUVB
$2.25B
$107K ﹤0.01%
+11,483
New +$131K
PAYS icon
2827
Paysign
PAYS
$723M
$107K ﹤0.01%
33,500
+9,342
+39% +$33.6K
SBBP
2828
DELISTED
Strongbridge Biopharma plc.
SBBP
$107K ﹤0.01%
36,100
-2,851
-7% -$7.53K
RMNI icon
2829
Rimini Street
RMNI
$445M
$106K ﹤0.01%
+17,268
New +$126K
SEAC
2830
DELISTED
Seachange International Inc
SEAC
$106K ﹤0.01%
4,095
-124
-3% -$2.92K
LMACU
2831
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$106K ﹤0.01%
10,040
KLXE icon
2832
KLX Energy Services
KLXE
$34.6M
$104K ﹤0.01%
10,900
-9,600
-47% -$109K
FF icon
2833
Future Fuel
FF
$257M
$102K ﹤0.01%
+10,619
New +$128K
HOFV
2834
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$101K ﹤0.01%
1,171
-1,343
-53% -$116K
CTAQ
2835
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$101K ﹤0.01%
+10,377
New +$101K
ALTO icon
2836
Alto Ingredients
ALTO
$315M
$100K ﹤0.01%
16,441
+5,441
+49% +$31.7K
OIS icon
2837
Oil States International
OIS
$536M
$100K ﹤0.01%
12,701
+1,348
+12% +$9.03K
ALR
2838
DELISTED
AlerisLife Inc
ALR
$100K ﹤0.01%
17,400
+6,626
+61% +$37.7K
HROW icon
2839
Harrow
HROW
$1.48B
$99K ﹤0.01%
10,700
-1,626
-13% -$13.9K
LHDX
2840
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$98K ﹤0.01%
+14,800
New +$93.3K
IDEX
2841
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$97K ﹤0.01%
+273
New +$97.5K
DFTX
2842
Definium Therapeutics
DFTX
$5.68B
$96K ﹤0.01%
+1,853
New +$97.3K
BCEL
2843
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$96K ﹤0.01%
11,234
+417
+4% +$4.27K
ASPS icon
2844
Altisource Portfolio Solutions
ASPS
$64.5M
$93K ﹤0.01%
1,313
-47
-3% -$2.73K
XWEL icon
2845
XWELL
XWEL
$8.7M
$93K ﹤0.01%
+3,005
New +$85.6K
OTIC
2846
DELISTED
Otonomy, Inc.
OTIC
$92K ﹤0.01%
41,400
+19,700
+91% +$45.5K
RESN
2847
DELISTED
Resonant Inc.
RESN
$91K ﹤0.01%
28,200
-3,578
-11% -$12.3K
MLSS icon
2848
Milestone Scientific
MLSS
$46.8M
$90K ﹤0.01%
36,700
+16,563
+82% +$40.2K
TOON icon
2849
Kartoon Studios
TOON
$38.7M
$90K ﹤0.01%
4,905
+2,455
+100% +$42.9K
SIGA icon
2850
SIGA Technologies
SIGA
$206M
$89K ﹤0.01%
14,164
+575
+4% +$3.95K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.